Abstract
The American Journal of Chinese MedicineVol. 08, No. 01n02, pp. 195-197 (1980) NEWS & VIEWSNo AccessChina Invents Male Birth Control PillWei WenWei WenChina Feature P.O. Box 522, Beijing, China Search for more papers by this author https://doi.org/10.1142/S0192415X80000165Cited by:8 Previous AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsRecommend to Library ShareShare onFacebookTwitterLinked InRedditEmail Remember to check out the Most Cited Articles! Check out our Chinese Medicine Titles today. Includes titles by Nobel Winner, Tu You You and more! FiguresReferencesRelatedDetailsCited By 8Anti-inflammatory Effects of Gossypol on Human Lymphocytic Jurkat Cells via Regulation of MAPK Signaling and Cell CycleChien-Wei Chen, Sindy Hu, Ke-Hung Tsui, Guey-Shyang Hwang and Szu-Tah Chen et al.22 August 2018 | Inflammation, Vol. 41, No. 6“Put It in Your Shoe It Will Make You Limp”: British Men’s Online Responses to a Male PillAmanda D. Wilson3 April 2018 | The Journal of Men’s Studies, Vol. 26, No. 3CottonLori Hinze and Russell Kohel24 August 2011The effect of gossypol on fast axonal transport and microtubule assemblyMartin Kanje, Per Ekström, Johanna Deinum and Margareta Wallin1 Apr 1986 | Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 856, No. 3Toxicological effects of gossypolA. A. Nomeir and M. B. Abou-donia1 Jan 1985Gossypol induces DNA strand breaks in human fibroblasts and sister chromatid exchanges in human lymphocytes in vitro.M Nordenskjold and B Lambert1 Apr 1984 | Journal of Medical Genetics, Vol. 21, No. 2Training toxicologists: the move from learning to understandingB. Max1 Jan 1984 | Trends in Pharmacological Sciences, Vol. 5The effect of the male contraceptive agent Gossypol on human lymphocytes in vitro: traditional chromosome breakage, micronuclei, sister chromatid exchange, and cell kinetics.Y C Tsui, M R Creasy and M A Hulten1 Apr 1983 | Journal of Medical Genetics, Vol. 20, No. 2 Recommended Vol. 08, No. 01n02 Metrics History Received 27 March 1979 PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.